Bull case
The bull case prices ECL at 22x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where ECL stock could go
The bull case prices ECL at 22x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
At 17x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 22x multiple contraction could push ECL down roughly 68% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Ecolab is a global provider of water treatment, hygiene, and infection prevention solutions for industrial, institutional, and healthcare customers. It generates revenue primarily through chemical sales and service contracts across three main segments—Global Industrial (~40% of sales), Global Institutional & Specialty (~35%), and Global Healthcare & Life Sciences (~25%). The company's moat lies in its mission-critical, recurring service model with high switching costs—once installed, its water treatment and cleaning systems create long-term customer lock-in.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.89/$1.90 | -0.5% | $4.0B/$4.0B | +0.1% |
| Q4 2025 | $2.07/$2.07 | +0.0% | $4.2B/$4.1B | +1.1% |
| Q1 2026 | $2.08/$2.07 | +0.5% | $4.2B/$4.2B | +0.1% |
| Q2 2026 | $1.70/$1.70 | +0.0% | $4.1B/$4.0B | +1.0% |
ECL beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $198 — implies -26.6% from today's price.
| Metric | ECL | S&P 500 | Basic Materials | 5Y Avg ECL |
|---|---|---|---|---|
| Forward PE | 32.4x | 18.8x+72% | 14.9x+118% | — |
| Trailing PE | 37.0x | 24.4x+51% | 23.6x+57% | 41.5x-11% |
| PEG Ratio | — | 1.66x | 1.23x | — |
| EV/EBITDA | 23.6x | 15.2x+55% | 11.0x+115% | 23.0x |
| Price/FCF | 39.9x | 20.7x+93% | 29.0x+38% | 39.5x |
| Price/Sales | 4.7x | 3.1x+53% | 1.9x+151% | 4.2x+13% |
| Dividend Yield | 0.98% | 1.91% | 1.41% | 1.07% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolECL generates $1.9B in free cash flow at a 11.8% margin — 12.7% ROIC signals a durable competitive advantage · returns 2.0% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.6 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
The bear case price target of $95 suggests significant downside risk due to potential valuation compression.
Analysts consider the Basic Materials sector outlook as a factor, which could negatively impact Ecolab's performance.
Not all products are available in all countries, which may limit revenue growth in certain regions.
Ecolab's competitive positioning in water treatment and hygiene markets could face pressure from rivals.
Forward EPS estimates under bear scenarios indicate potential earnings volatility and downside risk.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Ecolab is a global leader in water, hygiene, and infection prevention solutions, with a century-long history of innovation and a strong market position.
The company benefits from pricing momentum and margin expansion, as highlighted in previous bullish theses, contributing to stock appreciation.
Ecolab's recurring revenue model aligns well with steady economic growth and resilient demand, providing a stable financial foundation.
Analysts project a 12-month price target range of $270.87 to $309.56, reflecting confidence in Ecolab's growth rates and valuation metrics.
The company's water solutions for data centers represent a strong growth driver, as previously noted in bullish investment theses.
Ecolab operates in over 170 countries with $16 billion in annual sales and 48,000 employees, showcasing its extensive global reach and scalability.
A steady growth path and stable monetary policy in 2026 create a favorable backdrop for Ecolab's business execution and growth.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
ECL ECL Ecolab Inc. | $76.0B | 32.4x | +6.8% | 12.9% | Buy | +21.5% |
SHW SHW The Sherwin-Williams Company | $79.1B | 27.4x | +3.8% | 10.9% | Buy | +16.8% |
IFF IFF International Flavors & Fragrances Inc. | $19.6B | 17.3x | +0.8% | 7.8% | Buy | +14.9% |
RPM RPM RPM International Inc. | $13.8B | 19.7x | +4.1% | 8.8% | Buy | +15.4% |
FMC FMC FMC Corporation | $1.4B | 6.8x | +2.7% | -72.9% | Hold | +39.4% |
CHD CHD Church & Dwight Co., Inc. | $22.7B | 25.5x | +4.3% | 11.8% | Buy | +9.8% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
ECL returns 2.0% annually — 0.98% through dividends and 1.0% through buybacks.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.46 | — | — | — |
| 2025 | $2.68 | +13.6% | 1.0% | 2.1% |
| 2024 | $2.36 | +9.3% | 1.5% | 2.5% |
| 2023 | $2.16 | +4.9% | 0.0% | 1.1% |
| 2022 | $2.06 | +5.6% | 1.2% | 2.7% |
Common questions answered from live analyst data and company financials.
Ecolab Inc. (ECL) is rated Buy by Wall Street analysts as of 2026. Of 37 analysts covering the stock, 27 rate it Buy or Strong Buy, 9 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $327, implying +21.5% from the current price of $269. The bear case scenario is $87 and the bull case is $182.
The Wall Street consensus price target for ECL is $327 based on 37 analyst estimates. The high-end target is $345 (+28.2% from today), and the low-end target is $275 (+2.2%). The base case model target is $138.
ECL trades at 32.4x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for ECL in 2026 are: (1) Valuation de-rating — The bear case price target of $95 suggests significant downside risk due to potential valuation compression. (2) Earnings volatility — Forward EPS estimates under bear scenarios indicate potential earnings volatility and downside risk. (3) Sector outlook risk — Analysts consider the Basic Materials sector outlook as a factor, which could negatively impact Ecolab's performance. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates ECL will report consensus revenue of $17.2B (+6.8% year-over-year) and EPS of $7.35 (+0.6% year-over-year) for the upcoming fiscal year. The following year, analysts project $18.3B in revenue.
Ecolab Inc. is expected to report its next earnings on approximately 2026-08-04. Consensus expects EPS of $2.09 and revenue of $4.4B. Over recent quarters, ECL has beaten EPS estimates 50% of the time.
Ecolab Inc. (ECL) generated $1.9B in free cash flow over the trailing twelve months — a free cash flow margin of 11.8%. ECL returns capital to shareholders through dividends (1.0% yield) and share repurchases ($784M TTM).